Search Results - "Gibbs, Simon Dj" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting

Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting

by Venner, Christopher P, Gillmore, Julian D, Sachchithanantham, Sajitha, Mahmood, Shameem, Lane, Thirusha, Foard, Darren, Roussel, Murielle, Rannigan, Lisa, Gibbs, Simon Dj, Pinney, Jennifer H, Whelan, Carol J, Lachmann, Helen J, Hawkins, Philip N, Wechalekar, Ashutosh D
Published in Haematologica (Roma) (01.12.2014)

Get full text

Journal Article

Systemic Amyloidosis in England: an epidemiological study

Systemic Amyloidosis in England: an epidemiological study

by Pinney, Jennifer H., Smith, Colette J., Taube, Jessi B., Lachmann, Helen J., Venner, Christopher P., Gibbs, Simon D. J., Dungu, Jason, Banypersad, Sanjay M., Wechalekar, Ashutosh D., Whelan, Carol J., Hawkins, Philip N., Gillmore, Julian D.
Published in British journal of haematology (01.05.2013)

Get full text

Journal Article

Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant

Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant

by SATTIANAYAGAM, Prayman T, HAHN, Angelika F, WECHALEKAR, Ashutosh D, HAWKINS, Philip N, GILLMORE, Julian D, WHELAN, Carol J, GIBBS, Simon D. J, PINNEY, Jennifer H, STANGOU, Arie J, ROWCZENIO, Dorota, PFLUGFELDER, Peter W, FOX, Zoe, LACHMANN, Helen J
Published in European heart journal (01.05.2012)

Get full text

Journal Article

99m Technetium-Hydroxy-Diphosphate Tracer (99mTcHDP) Bone Scintigraphy: An Easily Accessible, Rapid, Non-Invasive Diagnostic Tool for Cardiac Amyloidosis

99m Technetium-Hydroxy-Diphosphate Tracer (99mTcHDP) Bone Scintigraphy: An Easily Accessible, Rapid, Non-Invasive Diagnostic Tool for Cardiac Amyloidosis

by Gibbs, Simon DJ, Wong, Caroline, Hare, James, Zimmet, Hendrik, Hocking, Jay, Schwarer, Anthony P, Ting, Stephen B
Published in Blood (02.12.2016)

Get full text

Journal Article

$Updated analysis of a phase I/II study of venetoclax in combination with daratumumab and dexamethasone, +/- bortezomib, in patients with relapsed/refractory multiple myeloma$

Updated analysis of a phase I/II study of venetoclax in combination with daratumumab and dexamethasone, +/- bortezomib, in patients with relapsed/refractory multiple myeloma

by Kaufman, Jonathan L., Baz, Rachid C., Harrison, Simon J., Quach, Hang, Ho, Shir-Jing, Vangsted, Annette J., Moreau, Philippe, Gibbs, Simon DJ, Salem, Ahmed H., Coppola, Sheryl, Ross, Jeremy A., Masud, Abdullah A., Westrup, Sally, Vue, Jenny, Maciag, Paulo Cesar, Bueno, Orlando, Bahlis, Nizar J.
Published in Journal of clinical oncology (20.05.2020)

Get full text

Journal Article

Seattle Regimen RIC-HSCT in Early-Phase Multiple Myeloma: A Multi-Centre Experience Demonstrating Very Low Treatment-Related Mortality and Rapid Graft-Versus-Myeloma Effect Associated with Graft-Versus-Host Disease

Seattle Regimen RIC-HSCT in Early-Phase Multiple Myeloma: A Multi-Centre Experience Demonstrating Very Low Treatment-Related Mortality and Rapid Graft-Versus-Myeloma Effect Associated with Graft-Versus-Host Disease

by Shipton, Michael J, Routledge, David JM, Bodagh, Neil, Cavet, James, Tholouli, Eleni, Kulkarni, Samar, Gibbs, Simon DJ
Published in Blood (03.12.2015)

Get full text

Journal Article

The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients

The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients

by Dungu, Jason, BSc, MRCP, Sattianayagam, Prayman T., MA, MRCP, Whelan, Carol J., MD, FRCP, Gibbs, Simon D.J., FRACP, FRCPA, Pinney, Jennifer H., BM, BS, MRCP, Banypersad, Sanjay M., MBChB, BMedSCi, MRCP, Rowczenio, Dorota, MSc, Gilbertson, Janet A., CSci FIBMS, Lachmann, Helen J., MD, FRCP, Wechalekar, Ashutosh, MD, FRCP, Gillmore, Julian D., MD, PhD, FRCP, Hawkins, Philip N., PhD, FRCP, FRCPath, FMedsci, Anderson, Lisa J., MD
Published in The American heart journal (01.07.2012)

Get full text

Journal Article

Inflammatory Bowel Disease and Systemic AA Amyloidosis

Inflammatory Bowel Disease and Systemic AA Amyloidosis

by Sattianayagam, Prayman T., Gillmore, Julian D., Pinney, Jennifer H., Gibbs, Simon D. J., Wechalekar, Ashutosh D., Gilbertson, Janet A., Rowczenio, Dorota, Hawkins, Philip N., Lachmann, Helen J.
Published in Digestive diseases and sciences (01.06.2013)

Get full text

Journal Article

Cyclophosphamide, Bortezomib and Dexamethasone (CVD) Therapy in AL Amyloidosis Is Associated with High Clonal Response Rates and Prolonged Progression Free Survival

Cyclophosphamide, Bortezomib and Dexamethasone (CVD) Therapy in AL Amyloidosis Is Associated with High Clonal Response Rates and Prolonged Progression Free Survival

by Venner, Christopher P., Gillmore, Julian D, Lane, Thirusha, Foard, Darren, Rannigan, Lisa, Gibbs, Simon DJ, Pinney, Jennifer, Whelan, Carol, Lachmann, Helen, Hawkins, Philip N, Wechalekar, Ashutosh
Published in Blood (18.11.2011)

Get full text

Journal Article

Complete and Very Good Partial Responses Are Attainable Endpoints in Elderly Patients (>75 years) with AL Amyloidosis and Are Associated with Improved Overall Survival

Complete and Very Good Partial Responses Are Attainable Endpoints in Elderly Patients (>75 years) with AL Amyloidosis and Are Associated with Improved Overall Survival

by Venner, Christopher P., Gillmore, Julian D, Lane, Thirusha, Foard, Darren, Rannigan, Lisa, Gibbs, Simon DJ, Pinney, Jennifer, Whelan, Carol, Lachmann, Helen, Hawkins, Philip N, Wechalekar, Ashutosh
Published in Blood (18.11.2011)

Get full text

Journal Article

A Matched Comparison of Cyclophosphamide, Bortezomib and Dexamethasone (CVD) Versus Cyclophosphamide, Thalidomide and Dexamethasone (CTD) in the Treatment of Mayo Cardiac Stage III Patients with AL Amyloidosis

A Matched Comparison of Cyclophosphamide, Bortezomib and Dexamethasone (CVD) Versus Cyclophosphamide, Thalidomide and Dexamethasone (CTD) in the Treatment of Mayo Cardiac Stage III Patients with AL Amyloidosis

by Venner, Christopher P, Lane, Thirusha, Foard, Darren, Rannigan, Lisa, Mahmood, Shameem, Gibbs, Simon DJ, Pinney, Jennifer, Banypersad, Sanjay, Dungu, Jason, Whelan, Carol, Lachmann, Helen, Gillmore, Julian D, Hawkins, Philip N, Wechalekar, Ashutosh
Published in Blood (16.11.2012)

Get full text

Journal Article

Treatment and Outcome of 267 Patients with IgM-Related AL Amyloidosis

Treatment and Outcome of 267 Patients with IgM-Related AL Amyloidosis

by Roussel, Murielle, Palladini, Giovanni, Gibbs, Simon DJ, Venner, Christopher P., Fermand, Jean-Paul, Lachmann, Helen J, Gillmore, Julian D, Hawkins, Philip N, Merlini, Giampaolo, Jaccard, Arnaud, Wechalekar, Ashutosh
Published in Blood (16.11.2012)

Get full text

Journal Article

A European Collaborative Study of Treatment Outcomes In 428 Patients with Systemic AL Amyloidosis

A European Collaborative Study of Treatment Outcomes In 428 Patients with Systemic AL Amyloidosis

by Wechalekar, Ashutosh D, Kastritis, Efstathios, Merlini, Giampaolo, Hawkins, Philip N, Dimopoulos, Meletios A., Gillmore, Julian D, Gibbs, Simon DJ, Palladini, Giovanni
Published in Blood (19.11.2010)

Get full text

Journal Article

PATTERNS OF LATE GADOLINIUM ENHANCEMENT PREDICT SURVIVAL IN CARDIAC AMYLOIDOSIS: A SYSTEMATIC REVIEW OF 95 CASES WITH AL OR TTR TYPE

PATTERNS OF LATE GADOLINIUM ENHANCEMENT PREDICT SURVIVAL IN CARDIAC AMYLOIDOSIS: A SYSTEMATIC REVIEW OF 95 CASES WITH AL OR TTR TYPE

by Dungu, Jason, Whelan, Carol J, Gibbs, Simon DJ, Pinney, Jennifer H, Banypersad, Sanjay M, Venner, Christopher P, Lachmann, Helen J, Wechalekar, Ashutosh, Gillmore, Julian D, Hawkins, Philip N, Anderson, Lisa J
Published in Journal of the American College of Cardiology (27.03.2012)

Get full text

Journal Article

Is There a Role for Thalidomide Maintenance in the Treatment of AL Amyloidosis?

Is There a Role for Thalidomide Maintenance in the Treatment of AL Amyloidosis?

by Gibbs, Simon DJ, Sattianayagam, Prayman T, Gillmore, Julian D, Offer, Mark, Lachmann, Helen J, Hawkins, Philip N, Wechalekar, Ashutosh D
Published in Blood (20.11.2009)

Get full text

Journal Article

A New Staging System for AL Amyloidosis Incorporating Serum Free Light Chains, cardiac Troponin-T and NT-ProBNP

A New Staging System for AL Amyloidosis Incorporating Serum Free Light Chains, cardiac Troponin-T and NT-ProBNP

by Wechalekar, Ashutosh D, Wassef, Nancy L, Gibbs, Simon DJ, Gillmore, Julian, Dike, Felicia, Lachmann, Helen, Sattianayagam, Prayman, Bradwell, Arthur, Hawkins, Philip N
Published in Blood (20.11.2009)

Get full text

Journal Article

In AL Amyloidosis, Both Oral Melphalan and Dexamethasone (Mel-Dex) and Risk-Adapted Cyclophosphamide, Thalidomide and Dexamethasone (CTD) Have Similar Efficacy as Upfront Treatment

In AL Amyloidosis, Both Oral Melphalan and Dexamethasone (Mel-Dex) and Risk-Adapted Cyclophosphamide, Thalidomide and Dexamethasone (CTD) Have Similar Efficacy as Upfront Treatment

by Gibbs, Simon DJ, Gillmore, Julian D, Sattianayagam, Prayman T, Offer, Mark, Lachmann, Helen J, Hawkins, Philip N, Wechalekar, Ashutosh D
Published in Blood (20.11.2009)

Get full text

Journal Article

Transient Post Chemotherapy Rise in NT Pro-BNP in AL Amyloidosis : Implications for Organ Response Assessment

Transient Post Chemotherapy Rise in NT Pro-BNP in AL Amyloidosis : Implications for Organ Response Assessment

by Gibbs, Simon DJ, De Cruz, Marna, Sattianayagam, Prayman T, Lachmann, Helen J, Gillmore, Julian D, Hawkins, Philip N, Wechalekar, Ashutosh D
Published in Blood (20.11.2009)

Get full text

Journal Article

Cyclophosphamide, Thalidomide and Dexamethasone (CTD) Versus Melphalan Plus Dexamethasone (MD) for Newly-Diagnosed Systemic AL Amyloidosis – Results From the UK Amyloidosis Treatment Trial

Cyclophosphamide, Thalidomide and Dexamethasone (CTD) Versus Melphalan Plus Dexamethasone (MD) for Newly-Diagnosed Systemic AL Amyloidosis – Results From the UK Amyloidosis Treatment Trial

by Gillmore, Julian, Cocks, Kim, Gibbs, Simon DJ, Sattianayagam, Prayman T, Lane, Thirusha, Lachmann, Helen, Schey, Stephen, Cavenagh, James D., Oakervee, Heather, Morgan, Gareth J, Mehta, Atul B, Bourne, Suzan, Skinner, E., Booth, G., Hawkins, Philip N, Wechalekar, Ashutosh D
Published in Blood (20.11.2009)

Get full text

Journal Article

Biochemical basis of the amyloid diseases

Biochemical basis of the amyloid diseases

by Gibbs, Simon D J, Hawkins, Philip N
Published in British journal of hospital medicine (London, England : 2005) (01.02.2010)

Get more information

Journal Article